165 related articles for article (PubMed ID: 25857773)
1. IMP-GMP specific cytosolic 5'-nucleotidase regulates nucleotide pool and prodrug metabolism.
Cividini F; Filoni DN; Pesi R; Allegrini S; Camici M; Tozzi MG
Biochim Biophys Acta; 2015 Jul; 1850(7):1354-61. PubMed ID: 25857773
[TBL] [Abstract][Full Text] [Related]
2. Human cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistance.
Hunsucker SA; Spychala J; Mitchell BS
J Biol Chem; 2001 Mar; 276(13):10498-504. PubMed ID: 11133996
[TBL] [Abstract][Full Text] [Related]
3. Lack of cross-resistance with gemcitabine and cytarabine in cladribine-resistant HL60 cells with elevated 5'-nucleotidase activity.
Schirmer M; Stegmann AP; Geisen F; Konwalinka G
Exp Hematol; 1998 Dec; 26(13):1223-8. PubMed ID: 9845378
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents.
Klanova M; Lorkova L; Vit O; Maswabi B; Molinsky J; Pospisilova J; Vockova P; Mavis C; Lateckova L; Kulvait V; Vejmelkova D; Jaksa R; Hernandez F; Trneny M; Vokurka M; Petrak J; Klener P
Mol Cancer; 2014 Jun; 13():159. PubMed ID: 24972933
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells.
Giovannetti E; Mey V; Loni L; Nannizzi S; Barsanti G; Savarino G; Ricciardi S; Del Tacca M; Danesi R
Pharmacol Res; 2007 Apr; 55(4):343-9. PubMed ID: 17296311
[TBL] [Abstract][Full Text] [Related]
6. Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies.
Galmarini CM; Jordheim L; Dumontet C
Leuk Lymphoma; 2003 Jul; 44(7):1105-11. PubMed ID: 12916861
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues.
Gallier F; Lallemand P; Meurillon M; Jordheim LP; Dumontet C; Périgaud C; Lionne C; Peyrottes S; Chaloin L
PLoS Comput Biol; 2011 Dec; 7(12):e1002295. PubMed ID: 22174667
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5'-nucleotidase II.
Cividini F; Cros-Perrial E; Pesi R; Machon C; Allegrini S; Camici M; Dumontet C; Jordheim LP; Tozzi MG
Int J Biochem Cell Biol; 2015 Aug; 65():222-9. PubMed ID: 26079827
[TBL] [Abstract][Full Text] [Related]
9. The purine analog fludarabine acts as a cytosolic 5'-nucleotidase II inhibitor.
Cividini F; Pesi R; Chaloin L; Allegrini S; Camici M; Cros-Perrial E; Dumontet C; Jordheim LP; Tozzi MG
Biochem Pharmacol; 2015 Mar; 94(2):63-8. PubMed ID: 25656700
[TBL] [Abstract][Full Text] [Related]
10. Cytosolic 5'-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation.
Pesi R; Petrotto E; Colombaioni L; Allegrini S; Garcia-Gil M; Camici M; Jordheim LP; Tozzi MG
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037008
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterization of recombinant bovine cytosolic 5'-nucleotidase IMP-GMP specific.
Allegrini S; Pesi R; Tozzi MG; Eriksson S
Adv Exp Med Biol; 1998; 431():231-5. PubMed ID: 9598065
[No Abstract] [Full Text] [Related]
12. Distinct roles for recombinant cytosolic 5'-nucleotidase-I and -II in AMP and IMP catabolism in COS-7 and H9c2 rat myoblast cell lines.
Sala-Newby GB; Freeman NV; Skladanowski AC; Newby AC
J Biol Chem; 2000 Apr; 275(16):11666-71. PubMed ID: 10766785
[TBL] [Abstract][Full Text] [Related]
13. Initial studies to define the physiologic role of cN-II.
Filoni DN; Pesi R; Careddu MG; Camici M; Allegrini S; Collavoli A; Scarfone I; Zucchi F; Galli A; Tozzi MG
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1155-60. PubMed ID: 22132970
[TBL] [Abstract][Full Text] [Related]
14. cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer.
Sève P; Mackey JR; Isaac S; Trédan O; Souquet PJ; Pérol M; Cass C; Dumontet C
Lung Cancer; 2005 Sep; 49(3):363-70. PubMed ID: 15923058
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside phosphotransferase activity of human colon carcinoma cytosolic 5'-nucleotidase.
Tozzi MG; Camici M; Pesi R; Allegrini S; Sgarrella F; Ipata PL
Arch Biochem Biophys; 1991 Dec; 291(2):212-7. PubMed ID: 1659319
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of cytosolic 5'-nucleotidase II (cN-II) reveals that its activity is essential for survival in astrocytoma cells.
Careddu MG; Allegrini S; Pesi R; Camici M; Garcia-Gil M; Tozzi MG
Biochim Biophys Acta; 2008 Aug; 1783(8):1529-35. PubMed ID: 18445485
[TBL] [Abstract][Full Text] [Related]
17. Stably transfected adherent cancer cell models with decreased expression of 5'-nucleotidase cN-II.
Bricard G; Cros-Perrial E; Machon C; Dumontet C; Jordheim LP
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):604-612. PubMed ID: 27906612
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of the novel cytosolic 5'-nucleotidase IIIB explain its preference for m7GMP.
Monecke T; Buschmann J; Neumann P; Wahle E; Ficner R
PLoS One; 2014; 9(3):e90915. PubMed ID: 24603684
[TBL] [Abstract][Full Text] [Related]
19. Human seminal plasma soluble 5'-nucleotidase: regulatory aspects of the dephosphorylation of nucleoside 5'-monophosphates.
Minelli A; Moroni M; Mezzasoma I
Biochem Mol Med; 1997 Jun; 61(1):95-101. PubMed ID: 9232203
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the involvement of cytosolic 5'-nucleotidase (cN-II) in the synthesis of guanine nucleotides from xanthosine.
Barsotti C; Pesi R; Giannecchini M; Ipata PL
J Biol Chem; 2005 Apr; 280(14):13465-9. PubMed ID: 15699053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
